CLICKS:  19,311   0 (0.00%)  19/08/2019 00:00

South Africa's Dis-Chem annual profit misses estimates

(Adds result details, industrial strike impact, share price reaction)

JOHANNESBURG, May 16 (Reuters) - South African drugstore chain Dis-Chem Pharmacies Ltd's full-year earnings rose by less than expected, the company said on Thursday, as prolonged industrial action offset the impact of price cuts and aggressive promotions.

Dis-Chem said headline earnings per share (HEPS) climbed to 85.4 cents in the year ended February from 79.6 cents per share a year earlier, but they still fell short of an average analysts' estimate of 87 cents from Refinitiv I/B/E/S.

Headline EPS, which strips out certain one-off items, is the most widely watched profit measure in South Africa.

"Unfortunately, the industrial action which began mid-November last year heavily impacted the group's performance in the current financial period," the firm said in a statement.

This translated to slower retail revenue growth of 9.7% to 19.6 billion rand, with comparable store revenue growth at 3.4%. Wholesale revenue grew by 11.2% to 14.5 billion rand.

Comparable store revenue was hurt by competitive pricing across the personal care and baby sectors, and by a Department of Health decision to implement only a small rise in the maximum price Dis-Chem is allowed by law to charge for some products.

At 0718 GMT, shares in Dis-Chem were down 3.4 percent at 26.60 rand.

About 2,300 Dis-Chem employees belonging to the National Union of Public Service and Allied Workers (NUPSAW) went on a national strike from November until April, demanding among other things a rise in the minimum wage.

Dis-Chem, which competes with Clicks Group, said as a result of the strike it incurred direct costs of 50.4 million rand and indirect costs of between 22.3 million rand and 26 million rand. ($1 = 14.2436 rand) (Reporting by Nqobile Dludla; editing by Gopakumar Warrier and Jan Harvey)

2019-05-16 09:21:58

© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.